The Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis
Study Details
Study Description
Brief Summary
The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in the three planes, the ability to perform certain everyday activities and the strength of forward elevation measured with a dynamometer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Secondary objectives:
-
To study the evolution of passive glenohumeral range of motion
-
To study the evolution of the global range of passive and active motion for each method used
-
To evaluate functional recovery (DASH)
-
To evaluate the impact on quality of life (SF36)
-
To study the difference in visual analog scale scores for pain during physical therapy sessions
-
Compare the two methods/groups after three months.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: GSC physcial therapy Patients included in this arm of the study will follow the Global Shoulder Concept physical therapy sequence. |
Procedure: GSC physical therapy
Global Shoulder Concept physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.
|
Active Comparator: Standard Patients in this arm of the study will follow the standard physical therapy sequence. |
Procedure: Standard physical therapy
Standard physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.
|
Outcome Measures
Primary Outcome Measures
- change in FI2S score [90 days]
Secondary Outcome Measures
- Change in visual analog scale for pain [Day 1 versus baseline]
- Change in visual analog scale for pain [Day 5 versus baseline]
- Change in visual analog scale for pain [Day 12 versus baseline]
- Change in visual analog scale for pain [Day 19 versus baseline]
- Change in visual analog scale for pain [Day 26 versus baseline]
- Change in visual analog scale for pain [Day 90 versus baseline]
- Scapulohumeral amplitude gain in 3 main directions [Day 1]
Passive and active mobility are evaluated by manual goniometry.
- Scapulohumeral amplitude gain in 3 main directions [Day 26]
Passive and active mobility are evaluated by manual goniometry.
- Scapulohumeral amplitude gain in 3 main directions [Day 90]
Passive and active mobility are evaluated by manual goniometry.
- Functional gain as measured by the DASH self questionnaire [Day 1]
- Functional gain as measured by the DASH self questionnaire [Day 5]
- Functional gain as measured by the DASH self questionnaire [Day 12]
- Functional gain as measured by the DASH self questionnaire [Day 19]
- Functional gain as measured by the DASH self questionnaire [Day 26]
- Functional gain as measured by the DASH self questionnaire [Day 90]
- FI2S score [Day 1]
- FI2S score [Day 5]
- FI2S score [Day 12]
- FI2S score [Day 19]
- FI2S score [Day 26]
- SF36 self questionnaire [Day 1]
- SF36 self questionnaire [Day 26]
- SF36 self questionnaire [Day 90]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
The patient must have given his/her informed and signed consent
-
The patient must be insured or beneficiary of a health insurance plan
-
painful, chronic tendinopathy (more than 3 months) of the rotator cuff, confirmed by MRI
Exclusion Criteria:
-
The patient is pregnant or breastfeeding
-
Any emergency situation
-
Non-mechanical tendinopathies (metabolic, neurological, capsulitis, reflex sympathetic dystrophy) and tendon surgery (tendon surgery and acromioplasty)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | CHU de Montpellier - Hôpital Lapeyronie | Montpellier | France | 34295 | |
2 | CHU de Nîmes - Hôpital Universitaire Carémeau | Nîmes Cedex 9 | France | 30029 |
Sponsors and Collaborators
- Centre Hospitalier Universitaire de Nīmes
Investigators
- Study Director: Dominique Richard, Centre Hospitalier Universitaire de Nîmes
- Principal Investigator: Arnaud Dupeyron, MD PhD, Centre Hospitalier Universitaire de Nîmes
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PHRIP/2011/DR-03
- 2011-A01168-33